The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Medicine > Amylin Pharmaceuticals, Inc.

Amylin Pharmaceuticals, Inc.
Nasdaq: AMLN
Change
symbol:
     
 NEWS FROM THE WIRES
Amylin shares plunge on concerns over diabetes drug
Jul 27 2001 07:24 AM PDT

Amylin says FDA panel rejects diabetes drug Symlin
Jul 26 2001 02:02 PM PDT

More WIRE STORIES about this company

 PROFILE
Amylin Pharmaceuticals may help diabetics gain the upper hand in their battle with the disease. The company develops therapies to treat diabetes and associated disorders based on the hormone amylin, which is believed to play an important role in the regulation of metabolism. Its lead drug candidate, SYMLIN, has shown an ability to help control blood sugar levels. Amylin believes its treatment is an alternative for patients who receive multiple injections of insulin daily. The development-stage firm is also developing the drug AC2993 for type 2 diabetes and licensed from Aventis the drug AC3056, which may fight metabolic disorders relating to cardiovascular disease.

 COMPETITION
Alteon Inc. (ALT)
Eli Lilly and Company (LLY)
Novo Nordisk A/S (NVO)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 0.10
1-Yr. Sales Growth: 0.0%
Employees: 151
Revenue per employee: $662.25

 KEY PEOPLE
• Joseph C. Cook
    CEO
• Mark G. Foletta
    CFO

 CONTACT INFO
9373 Towne Centre Dr.
San Diego, CA 92121
US
Phone: 858-552-2200
Fax: 858-552-2212
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001